-
公开(公告)号：US20200298003A1
公开(公告)日：2020-09-24
申请号：US16895402
申请日：2020-06-08
Applicant: Medtronic, Inc.
Inventor： Xusheng ZHANG , Yanina GRINBERG , Paul R. SOLHEIM , Troy E. JACKSON , Timothy A. EBELING , Vladimir P. NIKOLSKI
Abstract: An implantable medical device system is configured to detect a tachyarrhythmia from a cardiac electrical signal and start an ATP therapy delay period. The implantable medical device determines whether the cardiac electrical signal received during the ATP therapy delay period satisfies ATP delivery criteria. A therapy delivery module is controlled to cancel the delayed ATP therapy if the ATP delivery criteria are not met and deliver the delayed ATP therapy if the ATP delivery criteria are met.
-
2.发明申请公开(公告)号：US20170266442A1
公开(公告)日：2017-09-21
申请号：US15071231
申请日：2016-03-16
Applicant: Medtronic, Inc.
Inventor： Troy E. JACKSON
CPC classification number: A61N1/3621 , A61B5/0464 , A61B5/4836 , A61N1/0504 , A61N1/0563 , A61N1/3622 , A61N1/36514 , A61N1/3956 , A61N1/3962 , A61N1/3987
Abstract: An extra-cardiovascular implantable cardioverter defibrillator (ICD) system receives a cardiac electrical signal by an electrical sensing circuit via an extra-cardiovascular sensing electrode vector and senses cardiac events from the cardiac electrical signal. The ICD system detects tachycardia from the cardiac electrical signal and determines a tachycardia cycle length from the cardiac electrical signal. The ICD system determines an ATP interval based on the tachycardia cycle length and sets an extended ATP interval that is longer than the ATP interval. The ICD delivers ATP pulses to a patient's heart via an extra-cardiovascular pacing electrode vector different than the sensing electrode vector. The ATP pulses include a leading ATP pulse delivered at the extended ATP interval after a cardiac event is sensed from the cardiac electrical signal and a second ATP pulse delivered at the ATP interval following the leading ATP pulse.
-
公开(公告)号：US20150297905A1
公开(公告)日：2015-10-22
申请号：US14789008
申请日：2015-07-01
Applicant: Medtronic, Inc.
Inventor： Saul E. GREENHUT , Robert J. NEHLS , Walter H. OLSON , Xusheng ZHANG , Wade M. DEMMER , Troy E. JACKSON , James D. REINKE
CPC classification number: A61N1/3962 , A61N1/056 , A61N1/3621 , A61N1/36585 , A61N1/37288 , A61N1/3756 , A61N1/3987
Abstract: Techniques and systems for monitoring cardiac arrhythmias and delivering electrical stimulation therapy using a subcutaneous implantable cardioverter defibrillator (SICD) and a leadless pacing device (LPD) are described. For example, the SICD may detect a tachyarrhythmia within a first electrical signal from a heart and determine, based on the tachyarrhythmia, to deliver anti-tachyarrhythmia shock therapy to the patient to treat the detected arrhythmia. The LPD may receive communication from the SICD requesting the LPD deliver anti-tachycardia pacing to the heart and determine, based on a second electrical signal from the heart sensed by the LPD, whether to deliver anti-tachycardia pacing (ATP) to the heart. In this manner, the SICD and LPD may communicate to coordinate ATP and/or cardioversion/defibrillation therapy. In another example, the LPD may be configured to deliver post-shock pacing after detecting delivery of anti-tachyarrhythmia shock therapy.
Abstract translation: 描述了使用皮下植入式心律转复除颤器（SICD）和无引线起搏装置（LPD）监测心律不齐和递送电刺激治疗的技术和系统。 例如，SICD可以检测来自心脏的第一电信号内的快速性心律失常，并且基于快速性心律失常确定将抗心律失常休克疗法递送给患者以治疗所检测到的心律失常。 LPD可以接收来自SICD的通信，请求LPD向心脏提供抗心动过速起搏，并且基于由LPD感测到的心脏的第二电信号确定是否将心动过速（ATP）提供给心脏。 以这种方式，SICD和LPD可以通信以协调ATP和/或心脏复律/除颤疗法。 在另一个示例中，LPD可以被配置为在检测到抗快速性心律失常性休克疗法的递送之后递送后冲击起搏。
-
公开(公告)号：US20250072810A1
公开(公告)日：2025-03-06
申请号：US18730301
申请日：2023-02-14
Applicant: Medtronic, Inc.
Inventor： Michael W. HEINKS , Alfonso ARANDA HERNANDEZ , Timothy A. EBELING , Saul E. GREENHUT , Scott R. HAWKINSON , Troy E. JACKSON , Yuanzhen LIU , Irving J. SANCHEZ , James VANDER HEYDEN , Xusheng ZHANG
Abstract: A medical device comprises a sensing circuit configured to sense at least one cardiac electrical signal, sense first ventricular event signals from the at least one cardiac electrical signal according to a sensitivity setting set to a first amplitude; and a control circuit in communication with the sensing circuit, the control circuit configured to determine that the at least one cardiac electrical signal meets suspected undersensing criteria, in response to determining that the suspected undersensing criteria are met, perform a morphology analysis of a first cardiac signal segment acquired from a first cardiac electrical signal of the at least one cardiac electrical signal sensed by the sensing circuit over a first predetermined time interval, determine that the first cardiac signal segment is a first tachyarrhythmia segment based on the morphology analysis, and adjust the sensitivity setting from the first amplitude to a second amplitude less than the first amplitude in response to determining that the first cardiac signal segment is a first tachyarrhythmia segment.
-
公开(公告)号：US20230100431A1
公开(公告)日：2023-03-30
申请号：US17823055
申请日：2022-08-29
Applicant: Medtronic, Inc.
Inventor： Yuanzhen LIU , Alfonso ARANDA HERNANDEZ , Timothy A. EBELING , Saul E. GREENHUT , Michael W. HEINKS , Jean E. HUDSON , Troy E. JACKSON , Irving J. SANCHEZ , James A. VANDER HEYDEN , Xusheng ZHANG
Abstract: A medical device is configured to sense first ventricular event signals from a first cardiac electrical signal and sense second ventricular event signals from a second cardiac electrical signal. The medical device is configured to determine sensed event data in response to the first ventricular event signals and the second ventricular event signals. The medical device may select one of the first cardiac electrical signal or the second cardiac electrical signal for providing input for tachyarrhythmia detection based on the sensed event data.
-
Patent Agency Ranking
公开(公告)号：US20170095665A1
公开(公告)日：2017-04-06
申请号：US15382853
申请日：2016-12-19
Applicant: Medtronic, Inc.
Inventor： Wade M. DEMMER , Troy E. JACKSON , Paul A. BELK
IPC: A61N1/362 , A61B5/042 , A61B5/0456 , G06F19/00 , A61N1/368 , A61N1/39 , A61M5/172 , A61M5/142 , A61B5/00 , A61N1/365
CPC classification number: A61N1/3621 , A61B5/0031 , A61B5/0422 , A61B5/0456 , A61B5/4836 , A61B5/7282 , A61M5/142 , A61M5/14276 , A61M5/1723 , A61M2005/14208 , A61M2230/04 , A61M2230/40 , A61N1/365 , A61N1/368 , A61N1/3684 , A61N1/3962 , G06F19/00 , G06F19/3456 , G06F19/3468 , G06F19/3481 , G16H20/17
Abstract: A medical device performs a method for computing an estimate of a physiological variable. The method includes sensing a physiological signal and measuring an event of the physiological signal. The device initializes a value of a long-term metric of the event measurement, wherein the long-term metric corresponds to a time interval correlated to a response time of the physiological variable to changes in the event. The estimate of the long-term metric is updated in a memory of the medical device using a previous long-term metric and a current measurement of the event. The device detects a need for computing the physiological variable and computes an estimate of the physiological variable using the updated long-term metric.
-
公开(公告)号：US20220288387A1
公开(公告)日：2022-09-15
申请号：US17669294
申请日：2022-02-10
Applicant: Medtronic, Inc.
Inventor： Saul E. GREENHUT , Mark L. BROWN , Vincent P. GANION , Yanina GRINBERG , Troy E. JACKSON , Todd J. SHELDON , Shravya SRIGIRI , Paul R. SOLHEIM
Abstract: A medical device is configured to sense a cardiac electrical signal and detect an atrial tachyarrhythmia based on the sensed cardiac electrical signal. The medical device is configured to determine that far field oversensing criteria are met by the cardiac electrical signal during the detected atrial tachyarrhythmia. The medical device may detect termination of the detected atrial tachyarrhythmia in response to the far field oversensing criteria being met.
-
公开(公告)号：US20190054297A1
公开(公告)日：2019-02-21
申请号：US15677204
申请日：2017-08-15
Applicant: Medtronic, Inc.
Inventor： Xusheng ZHANG , Yanina GRINBERG , Paul R. SOLHEIM , Troy E. JACKSON , Timothy A. EBELING , Vladimir P. NIKOLSKI
Abstract: An implantable medical device system is configured to detect a tachyarrhythmia from a cardiac electrical signal and start an ATP therapy delay period. The implantable medical device determines whether the cardiac electrical signal received during the ATP therapy delay period satisfies ATP delivery criteria. A therapy delivery module is controlled to cancel the delayed ATP therapy if the ATP delivery criteria are not met and deliver the delayed ATP therapy if the ATP delivery criteria are met.
-
公开(公告)号：US20170043174A1
公开(公告)日：2017-02-16
申请号：US15334410
申请日：2016-10-26
Applicant: Medtronic, Inc.
Inventor： Saul E. GREENHUT , Robert J. NEHLS , Walter H. OLSON , Xusheng ZHANG , Wade M. DEMMER , Troy E. JACKSON , James D. REINKE
CPC classification number: A61N1/3962 , A61N1/056 , A61N1/3621 , A61N1/36585 , A61N1/37288 , A61N1/3756 , A61N1/3987
Abstract: Techniques and systems for monitoring cardiac arrhythmias and delivering electrical stimulation therapy using a subcutaneous implantable cardioverter defibrillator (SICD) and a leadless pacing device (LPD) are described. For example, the SICD may detect a tachyarrhythmia within a first electrical signal from a heart and determine, based on the tachyarrhythmia, to deliver anti-tachyarrhythmia shock therapy to the patient to treat the detected arrhythmia. The LPD may receive communication from the SICD requesting the LPD deliver anti-tachycardia pacing to the heart and determine, based on a second electrical signal from the heart sensed by the LPD, whether to deliver anti-tachycardia pacing (ATP) to the heart. In this manner, the SICD and LPD may communicate to coordinate ATP and/or cardioversion/defibrillation therapy. In another example, the LPD may be configured to deliver post-shock pacing after detecting delivery of anti-tachyarrhythmia shock therapy.
Abstract translation: 描述了使用皮下植入式心律转复除颤器（SICD）和无引线起搏装置（LPD）监测心律不齐和递送电刺激治疗的技术和系统。 例如，SICD可以检测来自心脏的第一电信号内的快速性心律失常，并且基于快速性心律失常确定将抗心律失常休克疗法递送给患者以治疗所检测到的心律失常。 LPD可以接收来自SICD的通信，请求LPD向心脏提供抗心动过速起搏，并且基于由LPD感测到的心脏的第二电信号确定是否将心动过速（ATP）提供给心脏。 以这种方式，SICD和LPD可以通信以协调ATP和/或心脏复律/除颤疗法。 在另一个示例中，LPD可以被配置为在检测到抗快速性心律失常性休克疗法的递送之后递送后冲击起搏。
-
公开(公告)号：US20230285756A1
公开(公告)日：2023-09-14
申请号：US18320180
申请日：2023-05-18
Applicant: Medtronic, Inc.
Inventor： Xusheng ZHANG , Yanina GRINBERG , Paul R. SOLHEIM , Troy E. JACKSON , Timothy A. EBELING , Vladimir P. NIKOLSKI
CPC classification number: A61N1/3622 , A61N1/3624 , A61N1/36507 , A61N1/37217 , A61N1/39622 , A61N1/3987 , A61N1/37512 , A61N1/3918
Abstract: An implantable medical device system is configured to detect a tachyarrhythmia from a cardiac electrical signal and start an ATP therapy delay period. The implantable medical device determines whether the cardiac electrical signal received during the ATP therapy delay period satisfies ATP delivery criteria. A therapy delivery module is controlled to cancel the delayed ATP therapy if the ATP delivery criteria are not met and deliver the delayed ATP therapy if the ATP delivery criteria are met.
-
-
-
-
-
-
-
-
-
Search Results
14
records
(took 0.012 seconds)
